Literature DB >> 16246467

Photopolymerized hydrogel carriers for live vaccine ballistic delivery.

R J Christie1, D J Findley, M Dunfee, R D Hansen, S C Olsen, D W Grainger.   

Abstract

Photopolymerized poly(ethylene glycol) (PEG)-crosslinked hydrogels were assessed for their ability to serve as a payload vehicle to deliver a viable bacterial vaccine (Brucella abortus strain RB51 (RB51) to bison in Yellowstone National Park) ballistically using thermoplastic degradable Biobullets. PEG modified with degradable glycolide or lactide oligomers capped with photopolymerizable methacrylate groups served to crosslink the hydrogel vaccine carrier inside commercial hydroxypropylcellulose Biobullets. Release of 1 microm diameter model fluorescent particles from hydrogels followed known degradation trends for glycolide- and lactide-modified PEG hydrogels. All particles were released from PEG-co-glycolide hydrogels after approximately 10 days and PEG-co-lactide hydrogels after approximately 45 days following gel degradation. Minimal particle release was observed from pure PEG dimethacrylate hydrogels over 40 days. P. aeruginosa (strain PAO1) and RB51 live vaccines exhibit excellent viability following exposure to photopolymerization encapsulation within these gel matrices. Hydrogels photopolymerized into the payload chamber of Biobullets exhibit similar ballistic properties to commercially available Biobullets and penetrate and remain intact when fired intramuscularly into live elk for release of their gel payload in the host.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16246467     DOI: 10.1016/j.vaccine.2005.05.048

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Device-based local delivery of siRNA against mammalian target of rapamycin (mTOR) in a murine subcutaneous implant model to inhibit fibrous encapsulation.

Authors:  Hironobu Takahashi; Yuwei Wang; David W Grainger
Journal:  J Control Release       Date:  2010-08-19       Impact factor: 9.776

Review 2.  Ebolavirus vaccines for humans and apes.

Authors:  Hugues Fausther-Bovendo; Sabue Mulangu; Nancy J Sullivan
Journal:  Curr Opin Virol       Date:  2012-05-04       Impact factor: 7.090

3.  Hydrogels as promising platforms for engineered living bacteria-mediated therapeutic systems.

Authors:  Shuangjiang Yu; Hongcheng Sun; Yongguang Li; Shu Wei; Jiayun Xu; Junqiu Liu
Journal:  Mater Today Bio       Date:  2022-09-15

4.  Formulation and delivery of vaccines: Ongoing challenges for animal management.

Authors:  Sameer Sharma; Lyn A Hinds
Journal:  J Pharm Bioallied Sci       Date:  2012-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.